Dimensional Fund Advisors LP lifted its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 26.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,735,182 shares of the company's stock after acquiring an additional 361,810 shares during the period. Dimensional Fund Advisors LP owned 3.61% of Nu Skin Enterprises worth $12,632,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of NUS. Amundi increased its position in Nu Skin Enterprises by 18.8% during the first quarter. Amundi now owns 18,564 shares of the company's stock worth $127,000 after purchasing an additional 2,941 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of Nu Skin Enterprises by 64.6% in the 1st quarter. AQR Capital Management LLC now owns 350,357 shares of the company's stock valued at $2,530,000 after purchasing an additional 137,475 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Nu Skin Enterprises in the 1st quarter valued at $162,000. Goldman Sachs Group Inc. grew its stake in shares of Nu Skin Enterprises by 7.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company's stock valued at $9,582,000 after buying an additional 88,088 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in shares of Nu Skin Enterprises by 9.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 764,052 shares of the company's stock valued at $6,105,000 after buying an additional 65,060 shares during the period. 82.84% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on NUS. Zacks Research raised Nu Skin Enterprises from a "strong sell" rating to a "hold" rating in a research report on Monday, April 13th. Weiss Ratings downgraded Nu Skin Enterprises from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Thursday, June 4th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Nu Skin Enterprises presently has a consensus rating of "Reduce".
View Our Latest Report on NUS
Nu Skin Enterprises Price Performance
Shares of NYSE NUS opened at $5.50 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.03 and a quick ratio of 1.34. Nu Skin Enterprises, Inc. has a 1-year low of $4.89 and a 1-year high of $14.62. The company has a market capitalization of $266.78 million, a price-to-earnings ratio of 5.00 and a beta of 0.98. The business has a 50-day moving average of $5.22 and a 200-day moving average of $7.01.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its earnings results on Friday, May 8th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.47%. The company had revenue of $320.61 million for the quarter, compared to analysts' expectations of $329.70 million. On average, equities analysts anticipate that Nu Skin Enterprises, Inc. will post 1 EPS for the current fiscal year.
Nu Skin Enterprises Profile
(
Free Report)
Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.
Founded in 1984 by Blake M.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.